Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 647-651

  Jing, Chen ^a   Huang, Zhijie ^a   Duan, Yuqin ^a   Xiao, Xinrong ^a   Zhang, Ru ^a   Jiang, Jianqing ^a  

^a The General Hospital of Chengdu Military Area   (China)

Author keywords

Esophageal cancer; Folate intake; Methylenetetrahydrofolate reductase; Polymorphisms; Prognosis

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHINA; COHORT ANALYSIS; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHINA; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866467260     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.647     Document Type: Article

References (42)

1. Bai JL, Zheng MH, Xia X, et al (2009). MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur J Cancer, 46, 1443-9.
2. Bailey LB, Gregory JF 3rd (1999). 3rd Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129, 919-922.
3. Blount BC, Mack MM, Wehr CM, et al (2007). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5.
4. Boccia S, Gianfagna F, Persiani R, et al (2007). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers, 12, 635-44.
5. Cao HX, Gao CM, Takezaki T, et al (2008). Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev, 9, 203-8.
6. Chen H, Tucker KL, Graubard BI, et al (2002). Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer, 42, 33-40.
7. Choi SW, Mason JB (2000). Folate and carcinogenesis: an integrated scheme. J Nutr, 130, 129-32.
8. Esteller M (2008). Epigenetics in cancer. N Engl J Med, 358, 1148-59.
9. Falk GW (2009). Risk factors for esophageal cancer development. Surg Oncol Clin N Am, 18, 469-85.
10. Fang JY, Xiao SD (2003). Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol, 38, 821-9.
11. Friso S, Choi SW, Girelli D, et al (2002). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA, 99, 5606-11.
12. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a commonmutation inmethylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
13. He YT, Zhang JH, Li Y, et al (2007). Correlation between a polymorphism in the methylene tetrahydrofolate reductase gene and susceptibility to carcinoma of the esophagus and gastric cardia. Chinese J Clinic Oncol, 34, 194-7.
14. Jain M, Tilak AR, Upadhyay R, et al (2008). Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol, 230, 247-51.
15. Jiang Q, Chen K, Ma X, et al (2005). Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev, 29, 146-54.
16. Kim YI (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev, 13, 511-9.
17. Yang CS (2000). Vitamin nutrition and gastroesophageal cancer. J Nutr, 130, S338-9.
18. Lamprecht SA, Lipkin M (2003). Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer, 3, 601-14.
19. Leclerc D, Rozen R (2007). Molecular genetics of MTHFR: polymorphisms are not all benign. Med Sci, 23, 297-302.
20. Lu C, Xie H, Wang FL, et al (2011). Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer, 11, 91.
21. Mayne ST, Risch HA, Dubrow R, et al (2001). Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10, 1055-62.
22. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
23. Morita M, Kumashiro R, Kubo N, et al (2010). Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol, 15, 126-34.
24. Wang JM, Xu B, Rao JY, et al (2007). Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol, 19, 171-6.
25. Wang Y, Guo W, He Y, et al (2007). Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control, 18, 143-52.
26. Sarbia M, Stahl M, von Weyhern C, et al (2006). The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Br J Cancer, 94, 203-7.
27. Shen H, Spitz MR, Wang LE, et al (2001). Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev, 10, 397-401.
28. Shitara K, Muro K, Ito S, et al (2010). Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer. Cancer Epidemiol Biomarkers Prev, 19, 1311-9.
29. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
30. Sun SX (2011). Folate Intake, Methylenetetrahydrofolate reductase Polymorphisms in association with esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 11, In press.
31. Suzuki T, Matsuo K, Hasegawa Y, et al (2007). One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci, 98, 1439-46.
32. Shrubsole MJ, Jin F, Dai Q, et al (2001). Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res, 61, 7136-41.
33. Stern LL, Mason JB, Selhub J, et al (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
34. Turek-Plewa J, Jagodzinski PP (2005). The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett, 10, 631-47.
35. Umar M, Upadhyay R, Khurana R, et al (2010). Evaluation of MTHFR677C>T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr Cancer, 62, 743-9.
36. Ulrich C (2010). Linking epidemiology to epigenomics-where are we today?. Cancer Prev Res, 3, 1505-8.
37. Upadhyay R, Jain M, Kumar S, et al (2008). Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol, 128, 199-204.
38. Wilcken B, Bamforth F, Li Z, et al (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet, 40, 619-25.
39. Xu WH, Shrubsole MJ, Xiang YB, et al (2007). Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev, 16, 281-7.
40. Yang CX, Matsuo K, Ito H, et al (2005). Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis, 26, 1285-90.
41. Yu MC, Yuan JM, Lu SC (2008). Alcohol, cofactors, and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol, 23, S92-7.
42. Zhang J, Zotz RB, Li Y, et al (2004). Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamouscell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol, 130, 574-80.